HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Dujon, A. Articles by Riquet, M. Search for Related Content PubMed Articles by Dujon, A. Articles by Riquet, M. Related Collections Lung - cancer

Eur J Cardiothorac Surg 2003;23:257
© 2003 Elsevier Science NL

Letter to the Editor

Reply to Margaritora et al.

Service de Chirurgie Thoracique, Hopital Europeen Georges Pompidou, 20–40 rue Leblanc, 75015 Paris, France

Received 30 October 2002; accepted 4 November 2002.

* Tel.: +33-1-5609-3450; fax: +33-1-5609-3380
e-mail: marc.riquet@hop.egp.ap-hop-paris.fr

Key Words: Neoadjuvant chemotherapy • Chemoradiotherapy • Mediastinoscopy

The first 20% of the full text of this article appears below.

We thank very much Margaritora and colleagues for giving us the opportunity to clarify our clinical conduct concerning N2. We routinely operate patients referred by different oncological centres, some following neoadjuvant chemotherapy (CT) or chemoradiotherapy (CRT) and others directly addressed for surgery. Also, over the same period, besides the . . . [Full Text of this Article]